NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) on Thursday said it is expanding the U.S. rollout of its TECNIS PureSee intraocular lens, an extended depth of focus lens designed to improve vision for patients undergoing cataract surgery.
The company said TECNIS PureSee is the first and only U.S. Food and Drug Administration-approved extended depth of focus intraocular lens without a warning on loss of contrast sensitivity, a measure of a patient's ability to distinguish objects from their background, particularly in low-light conditions.
Johnson & Johnson said the lens provides strong distance and intermediate vision with some near vision, while 97% of patients reported no very bothersome visual disturbances.
'With the full U.S. availability of TECNIS PureSee IOL, we are expanding access to an important extended depth of focus option that reflects our commitment to innovation, visual quality, and patient satisfaction,' said Erin Powers, President, Surgical Vision, North America, Johnson & Johnson.
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
